Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed in a closely watched study, dealing ‌a blow ...

Heart disease remains the leading cause of death in the United States, but the latest 2026 cholesterol management guidelines emphasize that prevention begins much earlier than many people realize.

A single dose of an experimental jab has been found to cut "bad" cholesterol levels by half within six months of treatment in ...

Clinical trials in the US and China reveal a groundbreaking nanodrug injection that could potentially control bad cholesterol ...

Researchers analyzed 22 studies to better understand how different sources of trans fats affect cardiometabolic health — and ...

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new ...

Artery plaque is more than cholesterol, involving lipids, inflammation, and calcium; managing LDL, blood pressure, blood ...

For years, heart doctors believed they might finally have a new way to prevent heart attacks and strokes in millions of ...

A new study led by investigators from Mass General Brigham reveals that certain features in the spleen hidden within imaging ...

A drug that heart doctors widely expected to become the next major weapon against heart attacks has failed in a large ...

Heart disease is increasingly affecting younger Indians, with some reaching bypass surgery earlier than expected. Cardiothoracic expert explains hidden risks, warning signs, treatment options and why ...

New 2026 ESC guidelines explain how cardiovascular and kidney disease influence each other and recommend wider kidney ...